NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY

metalloorganic compounds, medicine. SUBSTANCE: invention describes a novel chelate compound of oxovanadium (IV) with isonicotinic acid hydrazide of the formula: that shows an antidiabetic and selective an antimycobacterial activity that is the original combination of properties as compared with the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOSMANOV A.R, ZALJALJUTDINOVA L.N, NAZMUTDINOVA G.A, MURZAGALEEVA G.N, KIJASOV A.P, GALLJAMOV R.M, SHTYRLIN V.G, ZAKHAROV A.V, VALEEVA I.KH, KHAFIZ'JANOVA R.KH
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	metalloorganic compounds, medicine. SUBSTANCE: invention describes a novel chelate compound of oxovanadium (IV) with isonicotinic acid hydrazide of the formula: that shows an antidiabetic and selective an antimycobacterial activity that is the original combination of properties as compared with the known antidiabetic and antituberculosis preparations. EFFECT: valuable medicinal properties. 1 cl, 13 tbl, 7 ex